F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices

[ad_1]

The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.

[ad_2]

Source link